Safety And Feasibility Study Of Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) In Patients With Coronary Artery Disease Undergoing Native Vessel Intervention (PICSO)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01308125|
Recruitment Status : Completed
First Posted : March 3, 2011
Last Update Posted : April 23, 2012
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
|Condition or disease||Intervention/treatment||Phase|
|Stable Angina||Procedure: PICSO||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||10 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||PREPARE PICSO A Study To Evaluate The Safety And Feasibility Of Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) In Patients With Coronary Artery Disease Undergoing Native Vessel Intervention|
|Study Start Date :||October 2010|
|Actual Primary Completion Date :||March 2011|
|Actual Study Completion Date :||April 2011|
- Procedure: PICSO
- Baseline (hemodynamic) measurement
- Intra coronary
- Blood sampling
- LAD occlusion: for 3 min or until pain with and without PICSO
- Break recovery: the patient can recover from pain for 3 min
- CFIp: by a ComboWire advanced in the center lumen of an occlusion balloon.
- PICSO: start automatically and continued for 10 min.
- PCI/PICSO: concomitantly for the whole duration of the PCI intervention.
- 24h Follow up: additional blood samples every 6 hours (4 times)
- 30 days follow up.
- PICSO Impulse System
- PICSO Impulse Console
- PICSO Impulse Catheter
- No reported Adverse Events caused by PICSO [ Time Frame: 30 days ]
- The 30 days MACE is comparable to other patients undergoing PCI. [ Time Frame: 30 days after intervention ]
Number of patients of reported ADE described as:
- New onset of an acute coronary syndrome or newly documented heart failure, requiring therapy or hospitalization
- Pulmonary embolism
- Coronary sinus permanent occlusion
- Other Adverse Events
- The patients are hemodynamic stable during PICSO. [ Time Frame: 6 hours (during the whole intervention) ]
The hemodynamic is constantly monitored during the whole intervention and will be qualified by:
Arterial pressure, LAD pressure, LAD velocity, Coronary Sinus pressure, ECG
- Relative increase in collateral flow pressure index (CFpI) during LAD occlusion with and without PICSO. [ Time Frame: 6 hours (during the whole intervention) ]A ComboWire (VolcanoCorp, CA, USA) will be advanced in the center lumen of an occlusion balloon. This will allow performing the measurements below the experimental occlusion.
- The change of ST segment as recorded at Intra coronary ECG measures during balloon inflation. [ Time Frame: 6 hours (during the whole intervention) ]The presence or absence of ECG signs of myocardial ischemia during balloon occlusion will also be assessed on-line by means of the ST segment changes >0.1mV present on an intracoronary ECG lead obtained from the angioplasty guide wire placed distal to the stent (outside the OTW balloon) in the region on interest.
- Number of patients reaching collateral flow pressure index (CFpI) higher than 30% during PICSO. [ Time Frame: 6 hours (during the whole intervention) ]A ComboWire (VolcanoCorp, CA, USA) will be advanced in the center lumen of an occlusion balloon. This will allow performing the measurements below the experimental occlusion, see also above.
- Quantitative evaluation of pre-condition effect on relative increase of CFpI. [ Time Frame: 6 hours (during the whole intervention) ]A ComboWire (VolcanoCorp, CA, USA) will be advanced in the center lumen of an occlusion balloon. This will allow performing the measurements below the experimental occlusion. A comparision will be made between the LAD occlusion phase with or without PICSO.
- Duration from successful femoral vein cannulation until successful placement of PICSO Impulse catheter into the Coronary Sinus. [ Time Frame: 1 hours (at the begin of the intervention) ]For each case the time will be captured and the average time will be calculated from all enrolled cases.
- Intermittent elevation of coronary sinus pressure [ Time Frame: 6 hours (during the whole intervention) ]The coronary sinus pressure will be recorded during the whole intervention. The relative mean and max. increase during the PICSO-phase will be evaluated per Patient and over all cases.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||18 Years and older (Adult, Older Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
- Subjects (men or women) at least 18 years of age and
- Coronary artery disease as assessed by angiography and
- Clinical indication for PCI and
- Able to understand content of and willing to provide written informed consent
- Active and or treated malignancies within 12 months prior to Visit 1
- Anatomical complications (e.g. The system in not able to effectively occlude the coronary sinus)
- Presence of significant colleteral flow supplying the target vessel (Rentrop >1)
- Any significant systemic illness or medical condition that could lead to difficulty complying with the protocol; or any concurrent condition(s) which, in the investigator's opinion, would prohibit the subject from completing the study, or would not be in the best interest of the subject
- Bleeding or perforation during PCI, pericardial effusion and/or hematoma
- Cardiac arrest or arrhythmia requiring chest compressions or cardiopulmonary resuscitation
- Cardiogenic shock (Cardiac Index <1.8 L/min/meter-squared or as assessed by the investigator), pulmonary edema (Killip Class >2), or hemodynamic instability as assessed by the investigator at the time of cardiac catheterization
- Clinically significant renal disturbance (sMDRD calculated GFR≤30 mL/min/1,73m2)
- Coronary Sinus electrode in place
- Acute ST elevation myocardial infarction
- Previous Q-wave myocardial infarction in the target area
- History of acute myocardial infarction within 72h prior to screening
- Ejection fraction <20%
- History of stroke, any sequelae of a transient ischemic attack (TIA), reversible ischemic neurological defect (RIND) within 6 months prior to screening
- Left Bundle Branch Block
- Mitral regurgitation (MR) > grade I
- Mitral stenosis.
- Patient not currently in sinus rhythm
- Patients on cardiac resynchronization therapy (CRT) or scheduled for CRT implantation
- Patients with previous CABG or planned chronic total occlusion revascularization
- Pregnancy or active breast-feeding. Urine pregnancy tests will be performed on all women who are not post-menopausal for at least 1 year
- Registration in another interventional study
- Severe anemia at baseline (Hemoglobin <10 g/dl or <6.2 mmol/l)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01308125
|Academic Medical Center Amsterdam|
|Amsterdam, Netherlands, 1105 AZ|
|Principal Investigator:||Jan J. Piek, Prof||Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|
|Responsible Party:||Miracor Medical SA|
|Other Study ID Numbers:||
CIP 2009-03 PREPARE PICSO
|First Posted:||March 3, 2011 Key Record Dates|
|Last Update Posted:||April 23, 2012|
|Last Verified:||April 2012|
Coronary artery disease
collateral flow pressure index
pressure controlled intermittent coronary sinus occlusion
Coronary Artery Disease
Arterial Occlusive Diseases